Skip to main content
    P

    Pliant Therapeutics Inc (PLRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.69
    -0.00 (-0.55%)

    Market Cap: $43.21M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Pliant Therapeutics Inc (PLRX) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Pliant Therapeutics (PLRX) is expected to report earnings on Mar 9, 2027. In the quarter ended Sep 30, 2026, Pliant Therapeutics reported EPS of -$0.39, below the -$0.37 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    46%(12/26)
    Avg Surprise
    -1.33%

    Upcoming Estimates

    Reports Mar 9, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.38
    Range-$0.38 - -$0.38
    6 analysts
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.39
    Range-$0.39 - -$0.39
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.39-1.3%
    60d ago-$0.38-2.6%
    30d ago-$0.38-2.6%
    7d ago-$0.39-1.3%
    Current-$0.39
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    PLRX has an expected report date of Mar 9, 2027.

    Earnings History

    Of the 26 quarters below that had an estimate, PLRX beat 12, missed 13 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2020, when EPS landed 104.41% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.39-$0.37-$0.39 - -$0.36-5.41%MissN/A30 up, 2 downNov 12, 2026N/A
    Jun 30, 2026-$0.36-$0.33-$0.37 - -$0.32-9.09%MissN/A43 up, 0 downAug 11, 2026N/A
    Mar 31, 2026-$0.32-$0.36-$0.38 - -$0.33+11.11%BeatN/A51 up, 0 downMay 11, 2026N/A
    Dec 31, 2025-$0.35-$0.42-$0.42 - -$0.34+14.97%BeatN/A51 up, 0 downMar 11, 2026N/A
    Sep 30, 2025-$0.43-$0.52-$0.66 - -$0.41+17.31%BeatN/A80 up, 1 downNov 6, 2025N/A
    Jun 30, 2025-$0.71-$0.62-$1.09 - -$0.48-14.52%MissN/A83 up, 5 downAug 7, 2025N/A
    Mar 31, 2025-$0.92-$0.75-$0.87 - -$0.38-22.67%MissN/A95 up, 0 downMay 8, 2025N/A
    Dec 31, 2024-$0.82-$0.96-$1.05 - -$0.92+14.15%BeatN/A100 up, 0 downMar 3, 2025$2.27M
    Sep 30, 2024-$0.95-$0.98-$1.15 - -$0.87+3.06%BeatN/A121 up, 0 downNov 7, 2024N/A
    Jun 30, 2024-$0.92-$0.85-$0.93 - -$0.80-8.24%MissN/A120 up, 0 downAug 7, 2024N/A
    Mar 31, 2024-$0.78-$0.77-$0.83 - -$0.66-1.30%MissN/A130 up, 0 downMay 6, 2024N/A
    Dec 31, 2023-$0.69-$0.81-$1.15 - -$0.71+14.81%BeatN/A130 up, 0 downFeb 27, 2024$4.84M
    Sep 30, 2023-$0.70-$0.77-$0.88 - -$0.68+9.09%BeatN/A130 up, 0 downNov 9, 2023N/A
    Jun 30, 2023-$0.70-$0.69-$0.85 - -$0.51-1.45%MissN/A120 up, 0 downAug 9, 2023$248000
    Mar 31, 2023-$0.67-$0.67-$0.78 - -$0.590.00%In lineN/A120 up, 0 downMay 9, 2023$1.33M
    Dec 31, 2022-$0.72-$0.70-$0.75 - -$0.62-2.86%MissN/A120 up, 0 downMar 9, 2023$1.97M
    Sep 30, 2022-$0.65-$0.74-$0.83 - -$0.67+12.16%BeatN/A100 up, 0 downNov 8, 2022$1.48M
    Jun 30, 2022-$0.82-$0.81-$0.86 - -$0.77-1.23%MissN/A90 up, 0 downAug 8, 2022$4.99M
    Mar 31, 2022-$0.78-$0.74-$0.79 - -$0.70-5.41%MissN/A70 up, 0 downMay 9, 2022$1.25M
    Dec 31, 2021-$0.68-$0.76-$0.89 - -$0.64+10.53%BeatN/A7N/AFeb 28, 2022$2.00M
    Sep 30, 2021-$0.75-$0.69-$0.77 - -$0.63-8.70%MissN/A5N/ANov 9, 2021$1.61M
    Jun 30, 2021-$0.64-$0.67-$0.71 - -$0.60+4.48%BeatN/A5N/AAug 9, 2021$1.79M
    Mar 31, 2021-$0.64-$0.60-$0.66 - -$0.56-6.67%MissN/A5N/AMay 10, 2021$2.17M
    Dec 31, 2020-$0.54-$0.71-$1.05 - -$0.55+23.94%BeatN/A4N/AMar 16, 2021$4.46M
    Sep 30, 2020-$0.47-$0.60-$1.49 - -$0.55+21.67%BeatN/A4N/ANov 10, 2020$4.81M
    Jun 30, 2020-$1.39-$0.68-$1.05 - -$0.50-104.41%MissN/A4N/AAug 11, 2020$3.60M
    Mar 31, 2020-$0.20N/AN/AN/AN/AN/AN/AN/AJun 3, 2020$28.94M
    Jun 30, 2019-$0.21N/AN/AN/AN/AN/AN/AN/AJul 17, 2019N/A
    Last 28 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$2.41, after -$3.47 the year before. It was -$2.81 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$2.41N/A
    Dec 31, 2024-$3.47N/A
    Dec 31, 2023-$2.76N/A
    Dec 31, 2022-$2.97N/A
    Dec 31, 2021-$2.71N/A
    Dec 31, 2020-$2.81N/A

    Frequently Asked Questions About PLRX

    When is Pliant Therapeutics's next earnings date?

    Pliant Therapeutics's next earnings report is expected for Mar 9, 2027.

    Did PLRX beat earnings estimates last quarter?

    No. Pliant Therapeutics reported EPS of -$0.39 for the quarter ended Sep 30, 2026, below the -$0.37 estimate by 5.41%.

    What EPS do analysts expect from PLRX next quarter?

    The consensus EPS estimate for Pliant Therapeutics for the quarter ending Dec 31, 2026 is -$0.38 from 6 analysts, with estimates from -$0.38 to -$0.38.

    How often does PLRX beat earnings estimates?

    Pliant Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +0.73%.